Terri Powers - Diplomat Pharmacy Vice President Investor Relations
President
Terri Powers is Vice President Investor Relations of Diplomat Pharmacy since 2018.
| Tenure | 6 years |
| Phone | 888 720-4450 |
| Web | www.diplomat.is |
Diplomat Pharmacy Management Efficiency
The company has return on total asset (ROA) of (0.2088) % which means that it has lost $0.2088 on every $100 spent on assets. This is way below average. Diplomat Pharmacy's management efficiency ratios could be used to measure how well Diplomat Pharmacy manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 586.51 M in liabilities with Debt to Equity (D/E) ratio of 447.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Diplomat Pharmacy has a current ratio of 0.54, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Diplomat Pharmacy until it has trouble settling it off, either with new capital or with free cash flow. So, Diplomat Pharmacy's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Diplomat Pharmacy sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Diplomat to invest in growth at high rates of return. When we think about Diplomat Pharmacy's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michel Berthelin | Adient PLC | 54 | |
| William Matson | Analog Devices | 54 | |
| Neil Marchuk | Adient PLC | 60 | |
| Prashanth MahendraRajah | Analog Devices | 54 | |
| Anne Breton | BRP Inc | 52 | |
| Glen Vos | Aptiv PLC | 63 | |
| Mark Skonieczny | Adient PLC | 48 | |
| Josee Perreault | BRP Inc | 61 | |
| Jerome Dorlack | Adient PLC | 43 | |
| James Huang | Adient PLC | 59 | |
| David Paja | Aptiv PLC | 50 | |
| Jean Philibert | Analog Devices | 56 | |
| David Schneider | ServiceNow | 51 | |
| Monika Tornsen | Calliditas Therapeutics | 44 | |
| Joseph Massaro | Aptiv PLC | 54 | |
| AnneMarie LaBerge | BRP Inc | 58 | |
| Cathleen Ebacher | Adient PLC | 55 | |
| Margaret Seif | Analog Devices | 56 | |
| Joseph Hassett | Analog Devices | 66 | |
| Steven Pietkiewicz | Analog Devices | 58 | |
| Jose Jimenez | Aptiv PLC | N/A | |
Management Performance
| Return On Equity | -0.0059 | |||
| Return On Asset | -0.21 |
Diplomat Pharmacy Leadership Team
Elected by the shareholders, the Diplomat Pharmacy's board of directors comprises two types of representatives: Diplomat Pharmacy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diplomat. The board's role is to monitor Diplomat Pharmacy's management team and ensure that shareholders' interests are well served. Diplomat Pharmacy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diplomat Pharmacy's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shawn Tomasello, Independent Director | ||
| Jeffrey Park, Director | ||
| Brian Griffin, Chairman of the Board, CEO | ||
| Gary Kadlec, President Director | ||
| Daniel Davison, CFO, Treasurer | ||
| Philip Hagerman, Chairman of the Board, CEO, Co-Founder | ||
| Dan Davison, CFO, Treasurer | ||
| Gary Rice, Executive Vice President - Operations | ||
| Kenneth Klepper, Independent Director | ||
| Sean Whelan, CFO, Treasurer, Secretary, Director | ||
| Joel Saban, President | ||
| Robyn Peters, Executive Vice President of Sales and Payor Strategies | ||
| Benjamin Wolin, Independent Director | ||
| Paul Urick, President | ||
| Atheer Kaddis, Senior Vice President Sales and Business Development, Director | ||
| Asher Dewhurst, IR Contact Officer | ||
| Atul Kavthekar, CFO | ||
| Regina Benjamin, Independent Director | ||
| Dave Loschinskey, COO | ||
| Terri Powers, Vice President Investor Relations | ||
| David Dreyer, Independent Director |
Diplomat Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diplomat Pharmacy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0059 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (6.50) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 881.17 M | |||
| Shares Outstanding | 76 M | |||
| Shares Owned By Insiders | 23.99 % | |||
| Shares Owned By Institutions | 85.41 % | |||
| Number Of Shares Shorted | 2.98 M | |||
| Price To Earning | 207.10 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Diplomat Pharmacy in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Diplomat Pharmacy's short interest history, or implied volatility extrapolated from Diplomat Pharmacy options trading.
Pair Trading with Diplomat Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diplomat Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diplomat Pharmacy will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Diplomat Stock
If you are still planning to invest in Diplomat Pharmacy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diplomat Pharmacy's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |